Serial Number 79435549
640

Registration Progress

Application Filed
Sep 24, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

Basic Information

Serial Number
79435549
Filing Date
September 24, 2025
Drawing Code
2

Status Summary

Current Status
Active
Status Code
640
Status Date
Nov 11, 2025
Application
Pending
Classes
001 005 042 044

Rights Holder

Maxion Therapeutics Limited

99
Address
c/o Mishcon de Reya,
Africa House 70 Kingsway London WC2B 6AH
GB

Ownership History

Maxion Therapeutics Limited

Original Applicant
99
GB

Application History

6 events
Date Code Type Description Documents
Nov 12, 2025 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Nov 11, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
Nov 10, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 2, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Nov 2, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 30, 2025 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 001
Chemicals for use in industry and science; biochemicals, including polypeptides and antibodies for scientific, laboratory or research purposes; polypeptides and antibodies for use in the manufacture of pharmaceuticals and drugs; ion channel blocking antibodies for scientific, laboratory or research purposes; ion channel blocking antibodies for use in the manufacture of pharmaceuticals and drugs; antibodies derived from mini-protein toxins for scientific, laboratory or research purposes; antibodies derived from mini-protein toxins for use in the manufacture of pharmaceuticals and drugs.
Class 005
Pharmaceuticals and pharmaceutical preparations; drugs; antibodies for medical use; pharmaceuticals, drugs and pharmaceutical preparations incorporating antibodies, ion channel blocking antibodies or antibodies derived from mini-protein toxins; vaccines.
Class 042
Scientific and technological services and research and design relating thereto; drug discovery and drug development services; conducting or providing research and development services for others in the field of antibodies; laboratory services relating to the production of antibodies, ion channel blocking antibodies or antibodies derived from mini-protein toxins; antibody engineering; scientific services relating to the discovery, preclinical and clinical development of therapeutic products; information, advisory and consultancy services in relation to all of the aforesaid.
Class 044
Medical services; medical testing, analysis and diagnostic services in the field of antibodies; medical services connected with the treatment of diseases through the use of antibodies, ion channel blocking antibodies or antibodies derived from mini-protein toxins, or pharmaceuticals, drugs and pharmaceutical preparations derived from the aforesaid; information, advisory and consultancy services in relation to all of the aforesaid.

Classification

International Classes
001 005 042 044